Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
detroit blog main
detroit top stories
national blog main
national top stories
2
×
startups
2
×
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
angel investors
antibiotics
arboretum ventures
axial spondyloarthritis
bausch health
biogen
biotech
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
clinical trials
cluster headache
crispr
cultivation capital
deals
detroit
diagnostics
digital health
dihydroergotamine
dimitry nuyten
drug prices
What
approval
2
×
new
ann
announced
arbor
based
bio
biogen’s
biopharmaceutical
capital
companies
convo
developed
drug
earlier
eye
failures
fda
fifth
littered
medical
michigan
nash
news
prepares
price
raised
remains
road
roundup
scoring
seek
software
spun
startup
strategy
talk
technology
today
university
Language
Current search:
approval
×
startups
×
" national top stories "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
